We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SOLV:NYSESolventum Corporation Analysis

Data as of 2026-09-06 - not real-time

$91.69

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Solventum Corporation trades at $91.69, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. Over a rolling month the price has gained 17.5%. RSI sits at 64.3, which reads as approaching overbought, and MACD momentum is bearish. Price has been bracketed by support at $81.76 and resistance at $94.16.
The shares look fair, trading on 11.2 times earnings below a sector average of 30.6. Revenue is growing at 2.2% on a 17.3% profit margin.
The composite risk read is 4/10, putting it in moderate territory. With 30-day volatility of 33.7%, a beta of 0.62 and a maximum drawdown of 27.5%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to buy, carrying 6/10 conviction.

Top Market Events

SOLV's Q2 earnings and revenues beat estimates as organic sales increase 9.Solventum Corp SOLV beats Q2 expectations with 9.Healthcare solutions provider Solventum NYSE:SOLV reported Q2 CY2026 results , with sales up 2.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 77.39
  • MACD momentum is negative

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 11.2 versus sector average of 30.6
  • Trading above the 200-day average of 77.39

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • P/E of 11.2 versus sector average of 30.6
  • Profit margin of 17.3% is healthy
  • Return on equity of 34.0%

Key Metrics & Analysis

Financial Health

Revenue Growth2.20%
Profit Margin17.26%
P/E Ratio11.2
ROE33.96%
ROA2.70%
Debt/Equity110.31
P/B Ratio3.2
Op. Cash Flow$209.0M
Free Cash Flow$489.0M
Industry P/E30.6

Technical Analysis

TrendBullish
RSI64.3
Support$81.76
Resistance$94.16
MA 20$89.22
MA 50$84.01
MA 200$77.39
MACDBearish
VolumeDecreasing
Fear & Greed Index95.48

Valuation

Fair Value$11.25
Target Price$93.92
Upside/Downside2.44%
GradeFair
TypeBlend

Risk Assessment

Beta0.62
Volatility33.69%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.